NCT02569853 - DFN-11 Injection in Episodic Migraine With or Without Aura | Biotech Hunter

Enrollment

268

Participants

Timeline

Start Date

September 21, 2015

Primary Completion Date

May 30, 2017

Study Completion Date

February 26, 2018

Conditions

Episodic Migraine

Interventions

DRUG

DFN-11

OTHER

Placebo

Trial Locations (16)

14221

Dr. Reddy's Investigational Site #10, Williamsville

27405

Dr. Reddy's Investigational Site #26, Greensboro

29464

Dr. Reddy's Investigational Site #21, Mt. Pleasant

32256

Dr. Reddy's Investigational Site #24, Jacksonville

32751

Dr. Reddy's Investigational Site #23, Maitland

38119

Dr. Reddy's Investigational Site #25, Memphis

44122

Dr. Reddy's Investigational Site #15, Cleveland

48104

Dr. Reddy's Investigational Site #19, Ann Arbor

65807

Dr. Reddy's Investigational Site #13, Springfield

75231

Dr. Reddy's Investigational Site #14, Dallas

76054

Dr. Reddy's Investigational Site #16, Hurst

80404

Dr. Reddy's Investigational Site #18, Santa Monica

83716

Dr. Reddy's Investigational Site #27, Boise

84088

Dr. Reddy's Investigational Site #17, West Jordan

87102

Dr. Reddy's Investigational Site #12, Albuquerque

02472

Dr. Reddy's Investigational Site #20, Watertown